Company / FCF Margin
Xeris Biopharma Holdings, Inc. FCF Margin History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-194.8%
FY2021
5-year range
-194.8% / -194.8%
FY2021-FY2021
Trend
-
vs FY2020
Sector context
#98 of 134
Health Care
What the data says
At -194.8%, Xeris Biopharma Holdings, Inc.'s fcf margin ranks #98 of 134 in the Health Care sector.
Based on SEC 10-K filings.
-194.8% in FY2021.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#98 of 134 in Health CareTop 73% of 134This company -194.8% Sector average -637.8%
▼
+69.5% above sector average
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -194.8% | - |
| FY2020 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026